牛結核病診斷市場－全球產業規模、佔有率、趨勢、機會、預測：按檢測方法、地區和競爭格局分類，2021-2031年

全球牛結核病診斷市場預計將從 2025 年的 7.8212 億美元成長到 2031 年的 10.6439 億美元，複合年成長率為 5.27%。

在該領域，獸醫通訊協定和診斷方法，包括結核菌素皮膚試驗和γ干擾素檢測，用於確診牛分枝牛感染。這次疫情爆發的主要原因是各國政府為降低通用感染疾病威脅並遵守國際貿易法規（要求出口產品必須提供無疫病認證）而強制實施的嚴格根除計畫。這些監管要求需要對牛群進行持續檢測，以避免大規模疫情爆發造成的經濟損失。

然而，野生動物來源的持續存在對市場構成重大障礙，阻礙了根除工作的進展，並導致需要反覆進行成本高昂的篩檢檢測。近期統計數據凸顯了這項挑戰，顯示儘管採取了控制措施，問題的嚴重性依然不容忽視。例如，威爾斯農業聯盟（NFU Cymru）報告稱，2024年威爾斯因牛結核病被屠宰的牛超過13,000頭，比前一年成長了27%。這些數據表明，疾病控制工作仍面臨許多困難，不僅耗費資源，也限制了整個市場的效率。

市場促進因素

政府強制推行的根除和監測措施是市場擴張的主要動力。這些項目需要頻繁進行牛群檢測，因為監管機構制定了嚴格的檢測標準，從而確保了對診斷耗材的穩定需求。監管合規所需的檢測量龐大，也反映了這項工作的規模。例如，根據英國環境、食品和農村事務部的報告，2025年英格蘭有超過720萬牛接受了檢測。這項工作得到了大量公共資金的支持，正如英國農業、食品和海洋事務部發布的《2025年第三季牛結核病趨勢和支出》報告所示。報告顯示，截至2025年第三季度，愛爾蘭政府在牛根除項目上的支出達7,940萬歐元，比去年同期成長了20%。

此外，分子診斷和快速診斷方法的技術進步正在克服傳統方法的局限性，從而改變市場格局。例如，在已接種疫苗的牛中進行的DIVA（動態牛檢測）皮膚試驗等創新技術，在區分牛發揮著至關重要的作用。這些先進的診斷技術正迅速從研究階段過渡到實際應用階段。根據國家動植物衛生局於2025年10月發布的“牛疫苗計劃”，相關DIVA皮膚試驗的3期現場試驗已經啟動，至少有750頭動物正在接受測試。這些進展正在提高診斷準確性，強化徹底根除牛疫病的策略目標，並引領市場邁向高精度檢測解決方案。

市場挑戰

全球牛結核病診斷市場面臨的主要障礙之一是野生動物族群中持續存在的感染源。這種生物學現實導致了持續的再感染循環，即使經過嚴格的檢測和根除措施，牛仍面臨被獾、鹿等本地傳播媒介再次感染的風險。這種持續存在的威脅降低了標準檢測和撲殺通訊協定的有效性，迫使畜牧業優先考慮被動的危機管理，而非主動的市場成長。因此，野生動物疫情爆發的不確定性給畜牧業帶來了沉重的經濟負擔，限制了其用於實施全面診斷檢測策略的資金。

近期行業統計數據凸顯了這些經濟壓力的嚴峻性。根據阿爾斯特農民聯盟的報告顯示，預計到2024年，北愛爾蘭牛結核病的年發生率將上升至10.4%以上，而這一成長主要歸因於野生動物的傳播。如此高的發病率表明，無法控制野生動物攜帶者會導致疾病持續存在，並擾亂市場秩序。反過來，這又會阻礙永續成長，並削弱全球診斷工作的整體效率。

市場趨勢

診斷重點的關鍵轉折點是擴大對野生動物攜帶者進行監測的範圍。這超越了牛中心的通訊協定，旨在解決透過環境媒介持續傳播的問題。獸醫部門正在加強對獾等野生動物的法醫學檢查，從而能夠追蹤疾病傳播途徑並評估疫苗的有效性。這種積極主動的監測正在催生一些專業化的市場區隔領域，例如專門針對非牛品種的屍檢診斷試劑盒和快速現場採樣工具，並促進更精準的生物安全措施的發展。例如，《愛爾蘭農民日誌》在2025年5月報道，作為加強路邊疾病攜帶者監測計劃的一部分，北愛爾蘭農業、環境和農村事務部（DAERA）在2024年檢查了465具獾的屍體。

同時，從結核菌素皮膚試驗到分子診斷檢測的轉變顯著提高了疾病確診的速度和準確性。實驗室正穩步採用聚合酵素鏈鎖反應(PCR) 和全基因組定序 (WGS) 技術，以取代耗時的細菌培養。這些技術能夠快速鑑定牛結核病菌株並進行準確的流行病學追蹤。這項技術進步將顯著縮短牛流動限制的時間，並透過基因組精確識別局部感染叢集，支持策略性根除工作。正如英國動植物衛生局 (APHA) 於 2025 年 9 月發布的報告《2024 年英格蘭牛結核病》中所述，在 888 起新發疫情中成功進行了全基因組測序分析，這些疫情的官方無結核病認證已被撤銷，這凸顯了先進基因組分析技術在常規疾病管理中的應用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球牛結核病診斷市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依檢測類型（分子診斷檢測、血清學檢測、常規檢測）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美牛結核病診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲牛結核病診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區牛結核病診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲牛結核病診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美牛結核病診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球牛結核病診斷市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• IDEXX Laboratories, Inc.
• PBD Biotech Ltd
• Zoetis Inc.
• Innovative Diagnostics SAS
• Thermo Fisher Scientific Inc.
• Enfer Group
• AsureQuality Australia Pty Ltd.
• Bio-Rad Laboratories, Inc.
• Bionote USA Inc.
• Neogen Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Bovine Tuberculosis Diagnosis Market is projected to expand from USD 782.12 Million in 2025 to USD 1064.39 Million by 2031, registering a CAGR of 5.27%. This sector involves veterinary protocols and assays, including tuberculin skin tests and gamma-interferon detection, used to confirm Mycobacterium bovis infections in cattle. Growth is largely underpinned by strict government-mandated eradication schemes aimed at reducing zoonotic threats and adhering to international trade rules that demand disease-free certification for exports. These regulatory requirements necessitate continuous herd testing to avert the economic damages linked to widespread outbreaks.

Nevertheless, the market encounters a major obstacle due to persistent infection reservoirs in wildlife, which hampers eradication progress and demands repeated, expensive screening. This challenge is highlighted by recent statistics demonstrating the severity of the problem despite control efforts. For example, NFU Cymru reported in 2025 that over 13,000 cattle were slaughtered in Wales throughout 2024 because of bovine tuberculosis, representing a 27% rise from the prior year. Such figures underscore the continuing struggle of disease management, which places a strain on resources and restricts broader market efficiency.

Market Driver

The enforcement of mandatory government eradication and surveillance initiatives serves as the primary engine for market expansion, as regulatory authorities impose rigorous testing standards. These programs necessitate frequent herd screening, thereby guaranteeing a steady demand for diagnostic consumables. The magnitude of this effort is reflected in the high testing volumes needed for compliance; for instance, the Department for Environment, Food & Rural Affairs reported that over 7.2 million cattle tests were performed in England in 2025. This undertaking is supported by substantial public financing, as evidenced by the Department of Agriculture, Food and the Marine's 'Quarter 3 2025 Bovine TB Disease Trends and Expenditure' report, which noted that Irish government spending on the bovine TB eradication program reached €79.4 million by the third quarter of 2025, a 20% year-on-year increase.

Furthermore, technological progress in molecular and rapid diagnostic assays is transforming the market by overcoming the constraints of conventional methods. Innovations such as the Detect Infected among Vaccinated Animals (DIVA) skin test are pivotal, allowing for the distinction between infected and vaccinated cattle. These advanced diagnostics are quickly transitioning from research phases to practical deployment. According to the Animal and Plant Health Agency's 'Cattle Vaccine Project' announcement in October 2025, Phase 3 field trials for the companion DIVA skin test were initiated, involving the testing of at least 750 animals. Such developments improve diagnostic precision and bolster the strategic objective of total eradication, steering the market toward high-accuracy testing solutions.

Market Challenge

A significant hurdle for the Global Bovine Tuberculosis Diagnosis Market is the endurance of infection reservoirs within wildlife populations. This biological reality fuels a continuous cycle of re-infection, leaving cattle herds susceptible to re-contamination from local vectors like badgers or deer even after rigorous testing and clearance. This persistent threat diminishes the efficacy of standard test-and-slaughter protocols, compelling the industry to prioritize reactive crisis management over proactive market growth. Consequently, the unpredictability of outbreaks driven by wildlife places a financial strain on the livestock sector, restricting the capital available for implementing comprehensive diagnostic testing strategies.

The severity of this economic pressure is highlighted by recent industry statistics. As reported by the Ulster Farmers' Union, the annual herd incidence rate of bovine tuberculosis in Northern Ireland climbed to over 10.4 percent in 2024, a rise largely attributed to wildlife transmission dynamics. Such high incidence rates demonstrate how the failure to manage wildlife reservoirs prolongs the disease's presence, resulting in a volatile market landscape that impedes consistent growth and compromises the overall efficiency of global diagnostic measures.

Market Trends

A crucial shift in diagnostic focus is the expansion of wildlife reservoir surveillance and monitoring, which extends beyond cattle-centric protocols to tackle persistent infections in environmental vectors. Veterinary authorities are increasingly utilizing forensic testing on wildlife, such as badgers, to trace disease transmission routes and assess vaccination effectiveness. This active surveillance fosters a specialized market niche for post-mortem diagnostic kits and rapid field sampling tools tailored for non-bovine species, facilitating more precise biosecurity measures. For example, the Irish Farmers Journal reported in May 2025 that the Department of Agriculture, Environment and Rural Affairs (DAERA) tested 465 badger carcasses in Northern Ireland during 2024 as part of an intensified roadside surveillance project to monitor disease reservoirs.

Concurrently, the transition from tuberculin skin tests to molecular diagnostic assays is revolutionizing the speed and accuracy of disease confirmation. Laboratories are steadily substituting slow bacterial cultures with polymerase chain reaction (PCR) and Whole Genome Sequencing (WGS), technologies that offer rapid identification of Mycobacterium bovis strains and enable exact epidemiological tracing. This technological progression significantly shortens the duration herds spend under movement restrictions and aids strategic eradication by pinpointing local infection clusters with genomic accuracy. As noted in the Animal and Plant Health Agency's 'Bovine tuberculosis in England in 2024' report released in September 2025, Whole Genome Sequencing analysis was successfully performed for 888 new herd incidents where officially TB-free status was withdrawn, highlighting the integration of advanced genomics into routine disease management.

Key Market Players

• IDEXX Laboratories, Inc.
• PBD Biotech Ltd
• Zoetis Inc.
• Innovative Diagnostics SAS
• Thermo Fisher Scientific Inc.
• Enfer Group
• AsureQuality Australia Pty Ltd.
• Bio-Rad Laboratories, Inc.
• Bionote USA Inc.
• Neogen Corporation

Report Scope

In this report, the Global Bovine Tuberculosis Diagnosis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bovine Tuberculosis Diagnosis Market, By Tests

• Molecular Diagnostic Tests
• Serological Tests
• Traditional Tests

Bovine Tuberculosis Diagnosis Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bovine Tuberculosis Diagnosis Market.

Available Customizations:

Global Bovine Tuberculosis Diagnosis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bovine Tuberculosis Diagnosis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Tests (Molecular Diagnostic Tests, Serological Tests, Traditional Tests)
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Bovine Tuberculosis Diagnosis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Tests
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bovine Tuberculosis Diagnosis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Tests
  • 6.3.2. Canada Bovine Tuberculosis Diagnosis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Tests
  • 6.3.3. Mexico Bovine Tuberculosis Diagnosis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Tests

7. Europe Bovine Tuberculosis Diagnosis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Tests
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bovine Tuberculosis Diagnosis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Tests
  • 7.3.2. France Bovine Tuberculosis Diagnosis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Tests
  • 7.3.3. United Kingdom Bovine Tuberculosis Diagnosis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Tests
  • 7.3.4. Italy Bovine Tuberculosis Diagnosis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Tests
  • 7.3.5. Spain Bovine Tuberculosis Diagnosis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Tests

8. Asia Pacific Bovine Tuberculosis Diagnosis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Tests
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bovine Tuberculosis Diagnosis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Tests
  • 8.3.2. India Bovine Tuberculosis Diagnosis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Tests
  • 8.3.3. Japan Bovine Tuberculosis Diagnosis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Tests
  • 8.3.4. South Korea Bovine Tuberculosis Diagnosis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Tests
  • 8.3.5. Australia Bovine Tuberculosis Diagnosis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Tests

9. Middle East & Africa Bovine Tuberculosis Diagnosis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Tests
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bovine Tuberculosis Diagnosis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Tests
  • 9.3.2. UAE Bovine Tuberculosis Diagnosis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Tests
  • 9.3.3. South Africa Bovine Tuberculosis Diagnosis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Tests

10. South America Bovine Tuberculosis Diagnosis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Tests
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bovine Tuberculosis Diagnosis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Tests
  • 10.3.2. Colombia Bovine Tuberculosis Diagnosis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Tests
  • 10.3.3. Argentina Bovine Tuberculosis Diagnosis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Tests

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bovine Tuberculosis Diagnosis Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. IDEXX Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. PBD Biotech Ltd
• 15.3. Zoetis Inc.
• 15.4. Innovative Diagnostics SAS
• 15.5. Thermo Fisher Scientific Inc.
• 15.6. Enfer Group
• 15.7. AsureQuality Australia Pty Ltd.
• 15.8. Bio-Rad Laboratories, Inc.
• 15.9. Bionote USA Inc.
• 15.10. Neogen Corporation

16. Strategic Recommendations

17. About Us & Disclaimer